- Home
- GIW vs NRC Comparison
GIW vs NRC Comparison
Compare GIW & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GIW | NRC |
|---|---|---|
| Founded | 2025 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 361.1M | 428.2M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | GIW | NRC |
|---|---|---|
| Price | $9.95 | $20.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 144.5K | 68.2K |
| Earning Date | 01-01-0001 | 02-03-2026 |
| Dividend Yield | N/A | ★ 3.08% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.71 |
| Revenue | N/A | ★ $139,102,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $29.30 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.87 | $9.76 |
| 52 Week High | $10.05 | $22.79 |
Technical Indicators
Market Signals| Indicator | GIW | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 59.73 | 51.75 |
| Support Level | $9.89 | $18.43 |
| Resistance Level | $9.97 | $22.79 |
| Average True Range (ATR) | 0.02 | 0.97 |
| MACD | 0.00 | -0.13 |
| Stochastic Oscillator | 72.22 | 38.53 |
Price Performance
Historical ComparisonAbout GIW GigCapital8 Corp. Class A Ordinary Shares
GigCapital8 Corp is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.